Bill Blackburn is feeling fine after participating in the second round of a COVID-19 clinical trial.
The Alexandria restauranteur says he felt a sense of duty by being one of 30,000 people tested in the Phase 3 study to see whether mRNA-1273 can boost immune systems and create antibodies to kill the coronavirus.
“I was motivated by helping the greater good,” the 42-year-old Blackburn said. “Somebody has to do this.”
Blackburn’s wife works in clinical trials and signed him up.
“I told her I’d love to be involved in that, that I’d be a guinea pig,” Blackburn said. “I got a phone call about six weeks ago and they did some phone screening about my health, my weight, occupation and my lifestyle. Then they called me the next day and said that I met the profile for this study.”
Blackburn, who is a co-owner of the Homegrown Restaurant Group, twice drove out to Meridian Clinical Research in Rockville to get injections. Half of the participants received a placebo.
Dr. Brandon Essink, principal investigator and medical director at Meridian, called the study one of the most “important and impactful clinical research studies in our lifetime.”
Blackburn says he’s feeling healthy, and isn’t experiencing any side effects, which include headaches, swelling glands, fevers and joint pain.
“They call me twice a week, and I have an app on my phone where they send me messages to check my temperature and other things,” Blackburn said. “I am feeling 100% normal. I am experiencing no side effects.”
Courtesy photo
